EMBO Molecular Medicine

Papers
(The median citation count of EMBO Molecular Medicine is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Whole‐brain microscopy reveals distinct temporal and spatial efficacy of anti‐Aβ therapies228
Elongator and the role of its subcomplexes in human diseases183
IQCN disruption causes fertilization failure and male infertility due to manchette assembly defect120
Targeting the Leukemic stem cell protein machinery by inhibition of mitochondrial pyrimidine synthesis94
Depressive patient‐derived GABA interneurons reveal abnormal neural activity associated with HTR2C90
Targeting conformational changes in C‐reactive protein to inhibit pro‐inflammatory actions80
HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy78
Targetable Brg1‐CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking76
Activation of the integrated stress response is a vulnerability for multidrug‐resistant FBXW7‐deficient cells66
TFEB and TFE3 drive kidney cystogenesis and tumorigenesis66
Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain63
ASO targeting RBM3 temperature‐controlled poison exon splicing prevents neurodegeneration in vivo62
Metformin rescues migratory deficits of cells derived from patients with periventricular heterotopia62
Eosinophil‐derived IL‐4 is necessary to establish the inflammatory structure in innate inflammation60
Diagnostic biomarkers for active tuberculosis: progress and challenges59
Functions of double‐negative B cells in autoimmune diseases, infections, and cancers58
Systemic inflammation after stroke: implications for post‐stroke comorbidities58
Shear stress control of vascular leaks and atheromas through Tie2 activation by VE‐PTP sequestration54
Nerve regeneration by interferon intervention in aging brain54
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination53
Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy50
Single‐cell profiling of muscle‐infiltrating T cells in idiopathic inflammatory myopathies49
Active immunotherapy reduces NOTCH3 deposition in brain capillaries in a CADASIL mouse model49
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T‐cell lymphoma48
Optimizing the Cas13 antiviral train: cargo and delivery48
An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV‐248
Macrophage colony‐stimulating factor as a weapon against cytomegalovirus48
Advances in high‐throughput mass spectrometry in drug discovery48
Looking at a baby's heart through the lens of the mother's blood44
A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis44
A coordinated multiorgan metabolic response contributes to human mitochondrial myopathy43
Mitochondrial HSF1 triggers mitochondrial dysfunction and neurodegeneration in Huntington's disease42
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT42
Erratum To: ALX1‐related frontonasal dysplasia results from defective neural crest cell development and migration42
Sex differences and risk factors for bleeding in Alagille syndrome41
In vivo single‐cell transcriptomics reveal Klebsiella pneumoniae skews lung macrophages to promote infection41
Immuno(T)herapy for age‐related diseases40
Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation40
Elucidating effects of environmental exposure using human‐induced pluripotent stem cell disease modeling38
AAV induces hepatic necroptosis and carcinoma in diabetic and obese mice dependent on Pebp1 pathway38
The human host response to monkeypox infection: a proteomic case series study37
X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL37
The molecular biology of peritoneal metastatic disease37
A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond37
miR‐181a/b downregulation: a mutation‐independent therapeutic approach for inherited retinal diseases37
Systemic gene therapy rescues retinal dysfunction and hearing loss in a model of Norrie disease35
Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis34
IL‐27 produced during acute malaria infection regulates Plasmodium‐specific memory CD4+ T cells34
Trichothiodystrophy‐associated MPLKIP maintains DBR1 levels for proper lariat debranching and ectodermal differentiation33
Development of allogeneic iPS cell‐based therapy: from bench to bedside32
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer32
A progeroid syndrome caused by a deep intronic variant in TAPT1 is revealed by RNA/SI‐NET sequencing32
Answer to Gerber et al. “Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy”32
Viral anti‐inflammatory serpin reduces immuno‐coagulopathic pathology in SARS‐CoV‐2 mouse models of infection32
Nanobody‐mediated complement activation to kill HIV‐infected cells32
Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma31
NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA531
Molecular and functional properties of human Plasmodium falciparum CSP C‐terminus antibodies30
Patient‐ and xenograft‐derived organoids recapitulate pediatric brain tumor features and patient treatments30
TAPT1—at the crossroads of extracellular matrix and signaling in Osteogenesis imperfecta30
Full eradication of pre‐clinical human papilloma virus‐induced tumors by a lentiviral vaccine29
Targeting the liver to treat the eye27
Transfixed by transgenics: how pathology assumptions are slowing progress in Alzheimer's disease and related dementia research27
Alteration of microbiota antibody‐mediated immune selection contributes to dysbiosis in inflammatory bowel diseases27
Disrupting metformin adaptation of liver cancer cells by targeting the TOMM34/ATP5B axis27
Lack of the human choline transporter‐like protein SLC44A2 causes hearing impairment and a rare red blood phenotype27
Erratum To: MSTO1 is a cytoplasmic pro‐mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humans27
A whole‐genome scan for Artemisinin cytotoxicity reveals a novel therapy for human brain tumors27
Intestinal Apc‐inactivation induces HSP25 dependency26
Therapeutic activation of endothelial sphingosine‐1‐phosphate receptor 1 by chaperone‐bound S1P suppresses proliferative retinal neovascularization26
β‐Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T‐cell acute lymphoblastic leukemia26
Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants26
A nontyphoidal Salmonella serovar domestication accompanying enhanced niche adaptation25
Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple‐negative breast cancer25
Propionate reinforces epithelial identity and reduces aggressiveness of lung carcinoma25
Repurposing immunosuppressants for antileukemia therapy25
Erratum To: Early 5‐HT6 receptor blockade prevents symptom onset in a model of adolescent cannabis abuse24
mAb therapy controls CNS‐resident lyssavirus infection via a CD4 T cell‐dependent mechanism24
Erratum To: Long non‐coding RNA MALAT1 regulates retinal neurodegeneration through CREB signaling24
DGAT inhibition at the post‐absorptive phase reduces plasma FA by increasing FA oxidation24
Antagonizing microRNA‐19a/b augments PTH anabolic action and restores bone mass in osteoporosis in mice24
Cingulin regulates hair cell cuticular plate morphology and is required for hearing in human and mouse23
Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH)23
Maternal diet and gut microbiome composition modulate early‐life immune development23
Interferon regulates neural stem cell function at all ages by orchestrating mTOR and cell cycle23
IMPDH inhibition activates TLR‐VCAM1 pathway and suppresses the development of MLL‐fusion leukemia22
Liver‐directed gene therapy for ornithine aminotransferase deficiency22
A catalog of numerical centrosome defects in epithelial ovarian cancers22
Enhancement of efferocytosis through biased FPR2 signaling attenuates intestinal inflammation21
Tumor‐associated macrophages‐educated reparative macrophages promote diabetic wound healing21
Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ‐secretase activity21
iPSC‐based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation21
A high‐resolution 3D atlas of the spectrum of tuberculous and COVID‐19 lung lesions21
Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC‐driven lymphoma20
Immunotherapy targeting isoDGR‐protein damage extends lifespan in a mouse model of protein deamidation20
Targeting CRAC channels in inflammatory bowel disease20
Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancer20
Artificial sweeteners inhibit multidrug‐resistant pathogen growth and potentiate antibiotic activity19
Erratum To: Dual IRE1 RNase functions dictate glioblastoma development19
Pathological variants in TOP3A cause distinct disorders of mitochondrial and nuclear genome stability19
Paired box 6 gene delivery preserves beta cells and improves islet transplantation efficacy19
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin‐deficient mice19
Allelic effects on uromodulin aggregates drive autosomal dominant tubulointerstitial kidney disease18
Propylene glycol inactivates respiratory viruses and prevents airborne transmission18
Genetically modified macrophages accelerate myelin repair18
Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice18
Intratumoral co‐injection of NK cells and NKG2A‐neutralizing monoclonal antibodies18
Single‐cell transcriptomics reveals a senescence‐associated IL‐6/CCR6 axis driving radiodermatitis18
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary18
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease18
Acquired immunity against SARS‐CoV‐2 infection and vaccination17
Comparison of tumor‐informed and tumor‐naïve sequencing assays for ctDNA detection in breast cancer17
When dysbiosis meets dystrophy: an unwanted gut‐muscle connection17
Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy17
Lifting the iron curtain of vision17
Neuropilin‐1 (NRP1) expression distinguishes self‐reactive helper T cells in systemic autoimmune disease17
Microbial metabolites in chronic heart failure and its common comorbidities17
In situ mass spectrometry imaging reveals heterogeneous glycogen stores in human normal and cancerous tissues17
0.38476705551147